Open AccessMedicine

Juvenile Idiopathic Arthritis

M. Beresford

2011.6.1PEDIATRIC DRUGS

DOI: 10.2165/11588140-000000000-00000

tlooto Summary

This review focuses on recent advances in JIA, especially developments in its classification, validation of appropriate measures of holistic outcome, and the specific contribution of established and newer pharmacologic agents available for treating children and young people.

Abstract

Abstract is not available.

Citation format

BERESFORD, M. Juvenile idiopathic arthritis. PEDIATRIC DRUGS, 2011, 13: 161–173.